Results persist but gradually return toward baseline without ongoing support
Moreover, WES allows for the integration of pharmacogenomic information, particularly exonic variants in genes related to the Absorption, Distribution, Metabolism, and Excretion (ADME) of drugs, which may complement targeted assays traditionally used to calculate pharmacogenetic profiles, with the possibility of expanding the understanding of gene-drug interactions, and indirectly inform potential drugdrug and drug-nutrient interactionswhich will necessarily have to be calculated through other platforms (Whirl-Carrillo et al., 2012)
doi: 10.1128/IAI.01062-06 121 MaciverI.LatimerJ
Bc s c th khuyn bn nn b sung biotin t thc phm t nhin thay v vin ung
We defined two sets of genes, those either largely devoid of promoter bound NRF2 (Group I, green) or genes with high promoter bound NRF2 (Group II, purple) (Fig
Key Takeaway: The effectiveness of glutathione is determined by its delivery method, not just the dosage